Chicago Equity Partners’s CareDx CDNA Stock Holding History

Chicago Equity Partners’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11,650	Closed	-$263K	–	879
2019 Q3	$263K	Hold	11,650	–	–	0.01%	802
2019 Q2	$419K	Buy	+11,650	New	+$373K	0.02%	734
2019 Q1	–	Sell	-30,810	Closed	-$775K	–	848
2018 Q4	$775K	Sell	30,810 -37,820	-55%	-$972K	0.03%	533
2018 Q3	$1.98M	Buy	+68,630	New	+$1.28M	0.06%	380

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Chicago Equity Partners's CDNA Position: Q4 2019 in Review

Chicago Equity Partners sold out of CareDx (CDNA) in Q4 2019, closing a stake of 11,650 shares — an estimated $263K sold.

Chicago Equity Partners first reported a position in CDNA in Q3 2018 and held it in 4 quarters. The position peaked at $1.98M in Q3 2018. 159 funds tracked by Wall St. Rank hold CDNA as of Q4 2019.

Chicago Equity Partners reported no remaining CareDx position as of Q4 2019 after selling out during the quarter.
Chicago Equity Partners sold 11,650 CareDx shares in Q4 2019, an estimated $263K.
Chicago Equity Partners first reported a position in CareDx in Q3 2018 and held it in 4 quarters.
Chicago Equity Partners's CareDx position peaked at $1.98M in Q3 2018.
159 funds tracked by Wall St. Rank held CareDx as of Q4 2019.

Based on Chicago Equity Partners's 13F filing for Q4 2019, filed 10 Feb 2020.